Key Takeaways Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be ...

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

Mutations in one of the first human-isolated strains of H5N1 bird flu in the US were identified by the Texas Biomedical ...

CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

CDC officials said they opted to upgrade the advisory after seeing more patients whose illness cannot be traced back to an infected animal or bird. "That's a newer finding in the history of H5 - not ...

The CDC says the risk of bird flu to the general public is low, but public health experts say they are worried the virus ...

Discover outperforming stocks and invest ... process of developing a vaccine against bird flu, which is known in medical and scientific circles as the disease H5N1 or avian influenza.

Jefferies sees Arbutus (ABUS) potentially benefitting from vaccines being developed by Moderna (MRNA) and Pfizer (PFE)/GSK (GSK) for H5N1 avian flu. Read more here.

Moderna (MRNA) shares jumped more than 10% to lead S&P 500 gainers Tuesday, a day after the first bird-flu death was reported in the U.S. The biotech company is developing a vaccine for H5N1.

There is also a lot of uncertainty around the prospects of an avian flu vaccine for humans. Several major companies that manufacture them have said they could expedite the production of millions ...